The above link is to the latest research by Dr Sin Han Lee of Milford Hospital and Milford Molecular Laboratory, which suggest that non-B-conformational changes in HPV L1 gene DNA fragments bound to the AAHS adjuvant may be genotype related, in other words specific to HPV-16. In their press release, Sanevax asks the following questions and requests that the scientific community investigates this vaccine further:
- Once injected, how long will the HPV-16 L1 DNA fragments attached to aluminum remain in my body?
- Are the non-B conformation HPV fragments in Gardasil potentially harmful?
- Will the non-B conformation DNA fragments in Gardasil induce autoimmune disorders?
- Will the non-B conformation DNA get integrated in the genome causing mutagenesis and/or cancer?
The scientific community needs to investigate these potential risks immediately. Medical consumers need to know the risks as well as any potential benefits before they decide if Gardasil is right for them.
In the interest of public health and safety, the FDA needs to rescind approval for Gardasil until satisfactory answers are provided to the four questions above. The time for poke and hope is long since passed. Medical consumers need proof this vaccine is safe.